|
|
|
|
MATHYS MATTERS OCTOBER 2024 |
|
Welcome to Mathys Matters - your monthly update from Mathys & Squire, covering all the recent intellectual property and sector news/updates throughout October!
This month we’re shining a spotlight on the Mathys & Squire team being recommended in The Legal 500 2025 directory for their “unparalleled knowledge and experience in all areas of intellectual property”.
Our latest articles throughout October include: two CRISPR patents being pulled from EPO appeals causing procedural concerns, the EPO Board of Appeal finding no basis in the EPC for requiring description amendments, World Menopause Day and how intellectual property has impacted how women manage menopause, and commentary on the global increase of semiconductor patent applications following the growth of the AI sector.
Scroll down to read more! |
|
|
|
|
|
|
SPOTLIGHT OF THE MONTH
- Mathys & Squire teams recommended in The Legal 500 2025 directory for their “unparalleled knowledge and experience in all areas of intellectual property” - |
|
|
We are delighted to announce that Mathys & Squire has upheld its position in the 2025 edition of The Legal 500 for both PATMA: Patent Attorneys and PATMA: Trade Mark Attorneys categories. |
|
Patent Partners Chris Hamer, Alan MacDougall, Martin MacLean, Jane Clark, Paul Cozens, Dani Kramer, Philippa Griffin, James Wilding, Sean Leach and James Pitchford, as well as Alexander Robinson, Peter Arch and Laura Clews, who are newly ranked, are all featured in the 2025 edition of the directory. |
|
|
|
|
|
|
|
Two CRISPR patents pulled from EPO appeals citing procedural concerns
8 October 2024
In a surprise move, the representatives acting on behalf of UC Berkeley defending CRISPR patents in appeal proceedings before the European Patent Office (EPO) have withdrawn their approval of the texts of the patents thereby revoking them and bringing the appeal proceedings to an end. In this article, Partners Nicholas Fox, Martin MacLean, and David Hobson comment on the impacts that this decision may have and the concerns that may arise from this decision.
Read the article here |
|
| EPO Board of Appeal finds no basis in the EPC for requiring description amendments, and opts not to refer questions to the Enlarged Board
15 October 2024
An EPO Technical Board of Appeal concluded that there is no legal requirement for an applicant to amend the description of a patent application before grant. This case is notable for the depth of its legal analysis and because the Board has chosen not to refer questions to the Enlarged Board of Appeal. Partners Alexander Robinson and Stephen Garner provide an overview of this decision and its impact on this developing area of law.
Read the article here |
|
|
|
Emerging therapeutics and technology provide hope for menopause management
18 October 2024
The 18th of October is World Menopause Day and is an appropriate time to examine the recent progress made in women’s health, a sector that is often under researched and underfunded, and educate ourselves on the significant impact it can have. In this article, Associate Sarah Linnett discusses women’s symptoms and experiences, currently available pharmacological treatments and the rise in technology within the industry.
Read the article here |
|
| Semiconductor patent applications up 22% globally to 81,000 a year
22nd October 2024
There has been a 22% increase in global semiconductor patents filed, rising from 66,416 in 2022/3 to 80,892 in 2023/4 (year-end March 31), shows new research by Mathys & Squire. Commentary by Partner Edd Cavanna has been featured in Law360, WIPR - World IP Review, The Register and Communications Today discussing the global increase of semiconductor patent applications following the growth of the AI sector.
Read the article here |
|
|
|
|
|
|
|
|
|
Mathys & Squire T: +44 (0)20 7830 0000 E: info@mathys-squire.com
@Mathys_Squire www.mathys-squire.com
If you no longer wish to receive emails from us, click here to unsubscribe. |
|
